We’ve seen this movie before: Researchers present a study at a scientific meeting, then learn to their surprise (and, sometimes, chagrin) that a journal has published the data in a supplement or other edition.
The work was titled “Molecular mechanisms involved in resistance of CLL cells towards ABT-737, a specific BCL-2 inhibitor.” Gerald Cohen, of the University of Leicester, who led the study, told us:
There was nothing wrong with the data. I just did not feel that publishing an Abstract in this journal was particularly meaningful. The journal made a mistake in publishing the Abstract but there is nothing more to it than that. …We hope to publish in the future but it may need more work.
Cohen is one of the most-widely cited toxicologists in the world.
Administrative errors happen, of course. But it seems like this sort of thing is avoidable, and at the risk of ruffling feathers, we need to point out that the British Toxicology Society’s policy on meeting presentations is as explicit as can be:
Abstracts are published in the BTS official journal and behind the secure members area of the BTS website.
Toxicology puts out those meeting proceedings.